Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.55 |
| ▸ | CES1 | P23141 | 1/20 | 0.55 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.53 |
| ▸ | LSS | P48449 | 1/20 | 0.53 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.49 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.48 |
| ▸ | RORC | P51449 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.47 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.47 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | GSK3B | P49841 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13182691 | 0.78 | ALDH1A1 (0.61) | CES2CES1NPC1RAB9A | |
| SCHEMBL6800377 | 0.78 | GFER (0.54) | — | |
| SCHEMBL3655196 | 0.78 | CES2 (0.61) | CES2CES1TRPV1PTGS1SRD5A2 | |
| SCHEMBL2745400 | 0.76 | CES2 (0.59) | CES2CES1LSSSRD5A2PTPN1 | |
| SCHEMBL54839 | 0.76 | LMNA (0.53) | PTGS1NPC1RAB9A | |
| SCHEMBL2996638 | 0.76 | ALDH1A1 (0.59) | — | |
| N',N'-Dimethylbenzohydrazide SCHEMBL952727 | 0.75 | POLB (0.56) | NPC1RAB9A | |
| SCHEMBL4174548 | 0.75 | CES2 (0.64) | CES2CES1TRPV1PTGS1SRD5A2 | |
| SCHEMBL14880225 | 0.75 | CES2 (0.64) | CES2CES1TRPV1PTGS1SRD5A2 | |
| SCHEMBL7753604 | 0.74 | TRPV1 (0.59) | CES2CES1TRPV1PTGS1SRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10351557-B2 | Compounds for electronic devices | MERCK PATENT GMBH (DE) | 2019-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10351557-B2 | Compounds for electronic devices | CYP1B1, CYP2C19, CYP1A1 | CES2 143/4885CES1 1838/4885TRPV1 2416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.